Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

218
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
218
Cluster Sampling Method01:20

Cluster Sampling Method

13.9K
Appropriate sampling methods ensure that samples are drawn without bias and accurately represent the population. Because measuring the entire population in a study is not practical, researchers use samples to represent the population of interest.
To choose a cluster sample, divide the population into clusters (groups) and then randomly select some of the clusters. All the members from these clusters are in the cluster sample. For example, if you randomly sample four departments from your...
13.9K
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

496
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
496
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

221
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
221
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

5.0K
The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
5.0K
Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

227
Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
227

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Bayesian functional concurrent zero-inflated Dirichlet-multinomial regression model with application to infant microbiome.

Biostatistics (Oxford, England)·2026
Same author

Melding wildlife surveys to improve conservation inference.

Biometrics·2023
Same author

A Bayesian joint model for compositional mediation effect selection in microbiome data.

Statistics in medicine·2023
Same author

A Bayesian zero-inflated Dirichlet-multinomial regression model for multivariate compositional count data.

Biometrics·2023
Same author

Infinite hidden Markov models for multiple multivariate time series with missing data.

Biometrics·2022
Same author

Bayesian continuous-time hidden Markov models with covariate selection for intensive longitudinal data with measurement error.

Psychological methods·2021
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

Related Experiment Video

Updated: Jan 6, 2026

Assisted Selection of Biomarkers by Linear Discriminant Analysis Effect Size LEfSe in Microbiome Data
04:57

Assisted Selection of Biomarkers by Linear Discriminant Analysis Effect Size LEfSe in Microbiome Data

Published on: May 16, 2022

17.2K

A Bayesian semiparametric mixture model for clustering zero-inflated microbiome data.

Suppapat Korsurat1, Matthew D Koslovsky1

  • 1Department of Statistics, Colorado State University, Fort Collins, CO, 80523, United States.

Biometrics
|September 23, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a new Bayesian model for analyzing human microbiome data. The method effectively identifies subgroups within microbial compositions, crucial for understanding health and disease links.

Keywords:
compositional dataenterotypesmixture modelsmultivariate count data

More Related Videos

A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

457
Divergence of Root Microbiota in Different Habitats based on Weighted Correlation Networks
09:49

Divergence of Root Microbiota in Different Habitats based on Weighted Correlation Networks

Published on: September 25, 2021

4.8K

Related Experiment Videos

Last Updated: Jan 6, 2026

Assisted Selection of Biomarkers by Linear Discriminant Analysis Effect Size LEfSe in Microbiome Data
04:57

Assisted Selection of Biomarkers by Linear Discriminant Analysis Effect Size LEfSe in Microbiome Data

Published on: May 16, 2022

17.2K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

457
Divergence of Root Microbiota in Different Habitats based on Weighted Correlation Networks
09:49

Divergence of Root Microbiota in Different Habitats based on Weighted Correlation Networks

Published on: September 25, 2021

4.8K

Area of Science:

  • Microbiology
  • Bioinformatics
  • Statistical Modeling

Background:

  • Human microbiome research aims to link microbial composition to health and disease.
  • Existing clustering methods struggle with complex, zero-inflated microbiome data and often require pre-specifying the number of clusters.
  • This limitation can introduce bias in identifying meaningful subgroups.

Purpose of the Study:

  • To develop a novel Bayesian semiparametric mixture modeling framework for microbiome data.
  • To simultaneously determine the number of clusters and allocate individuals to them.
  • To address the challenges posed by zero-inflation and compositional nature of microbiome data.

Main Methods:

  • A Bayesian semiparametric mixture model was developed.
  • The model is designed for zero-inflated multivariate compositional count data.
  • Performance was evaluated through simulations and applied to a real-world gut microbiome dataset.

Main Results:

  • The proposed Bayesian framework effectively identifies subgroups in microbiome data.
  • The method accurately determines the number of clusters without prior assumptions.
  • Simulations confirmed superior clustering performance compared to existing methods, especially with zero-inflated data.

Conclusions:

  • The novel Bayesian modeling framework offers a robust approach for microbiome subgroup discovery.
  • Accurate identification of microbial subgroups can advance understanding of gut microbial composition in diseases like diarrhea.
  • This method improves inference by accommodating data complexities and learning the number of clusters simultaneously.